Open Access
ARTICLE
Chang-Eui Hong1,2,3, Su-Yun Lyu1,2,3,*
1 Department of Pharmacy; Sunchon National University, Suncheon, 57922, Republic of Korea
2 Smart Beautytech Research Institute, Sunchon National University, Suncheon, 57922, Republic of Korea
3 Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, Suncheon, 57922, Republic of Korea
* Corresponding Author: Su-Yun Lyu. Email:
(This article belongs to the Special Issue: Natural Product-Based Anticancer Drug Discovery)
BIOCELL https://doi.org/10.32604/biocell.2025.075574
Received 04 November 2025; Accepted 24 December 2025; Published online 14 January 2026
View
Download
Like
The progress of combination therapy with immune checkpoint inhibitors in breast cancer
KAIMIN FAN, JUNWEI WENGLA-D-B1, a novel Abemaciclib derivative, exerts anti-breast cancer effects through CDK4/6
LING MA, ZIRUI JIANG, XIAO HOU,...